124 related articles for article (PubMed ID: 32749684)
21. Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients.
Grover S; Stoffel EM; Bussone L; Tschoegl E; Syngal S
Clin Gastroenterol Hepatol; 2004 Sep; 2(9):813-9. PubMed ID: 15354282
[TBL] [Abstract][Full Text] [Related]
22. Increasing Appropriate BRCA1/2 Mutation Testing: The Role of Family History Documentation and Genetic Counseling in a Multidisciplinary Clinic.
Kishan AU; Gomez CL; Dawson NA; Dvorak R; Foster NM; Hoyt A; Hurvitz SA; Kusske A; Silver EL; Tseng C; McCloskey SA
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):634-641. PubMed ID: 27619940
[TBL] [Abstract][Full Text] [Related]
23. Genetic and familial factors influencing breast, colon, prostate and lung cancers.
Stein QP; Flanagan JD
S D Med; 2010; Spec No():16-22. PubMed ID: 20397487
[TBL] [Abstract][Full Text] [Related]
24. Health beliefs associated with readiness for genetic counseling among high risk breast cancer survivors.
Reblin M; Kasting ML; Nam K; Scherr CL; Kim J; Thapa R; Meade CD; Lee MC; Pal T; Quinn GP; Vadaparampil ST
Breast J; 2019 Jan; 25(1):117-123. PubMed ID: 30488655
[TBL] [Abstract][Full Text] [Related]
25. Higher levels of central adiposity in healthy premenopausal women with family histories of premenopausal breast cancer.
Dettenborn L; James GD; Britton JA; Bovbjerg DH
Am J Hum Biol; 2008; 20(3):355-8. PubMed ID: 18161037
[TBL] [Abstract][Full Text] [Related]
26. Work changes and individual, cancer-related, and work-related predictors of decreased work participation among African American cancer survivors.
Hastert TA; Kirchhoff AC; Banegas MP; Morales JF; Nair M; Beebe-Dimmer JL; Pandolfi SS; Baird TE; Schwartz AG
Cancer Med; 2020 Dec; 9(23):9168-9177. PubMed ID: 33159501
[TBL] [Abstract][Full Text] [Related]
27. Improving comprehension of genetic counseling for hereditary breast and ovarian cancer clients with a visual tool.
Tea MM; Tan YY; Staudigl C; Eibl B; Renz R; Asseryanis E; Berger A; Pfeiler G; Singer CF
PLoS One; 2018; 13(7):e0200559. PubMed ID: 30001421
[TBL] [Abstract][Full Text] [Related]
28. Familial risk of colo-rectal cancer in a low incidence area in southern Italy.
Centonze S; Boeing H; Leoci C; Bonfiglio C; Guerra V; Misciagna G
Eur J Epidemiol; 1993 Jan; 9(1):26-32. PubMed ID: 8472798
[TBL] [Abstract][Full Text] [Related]
29. How I Do It: Genetic counseling and genetic testing for inherited prostate cancer.
Giri VN; Gross L; Gomella LG; Hyatt C
Can J Urol; 2016 Apr; 23(2):8247-53. PubMed ID: 27085833
[TBL] [Abstract][Full Text] [Related]
30. Cancer Counseling of Low-Income Limited English Proficient Latina Women Using Medical Interpreters: Implications for Shared Decision-Making.
Kamara D; Weil J; Youngblom J; Guerra C; Joseph G
J Genet Couns; 2018 Feb; 27(1):155-168. PubMed ID: 28791541
[TBL] [Abstract][Full Text] [Related]
31. The Detroit Research on Cancer Survivors (ROCS) Pilot Study: A Focus on Outcomes after Cancer in a Racially Diverse Patient Population.
Beebe-Dimmer JL; Albrecht TL; Baird TE; Ruterbusch JJ; Hastert T; Harper FWK; Simon MS; Abrams J; Schwartz KL; Schwartz AG
Cancer Epidemiol Biomarkers Prev; 2019 Apr; 28(4):666-674. PubMed ID: 30482875
[TBL] [Abstract][Full Text] [Related]
32. An update on risk assessment for familial and hereditary colorectal cancer.
Edelman EA; Reed EK
J Am Assoc Nurse Pract; 2019 Jun; 31(6):327-329. PubMed ID: 31181053
[TBL] [Abstract][Full Text] [Related]
33. The impact of direct-to-consumer personal genomic testing on perceived risk of breast, prostate, colorectal, and lung cancer: findings from the PGen study.
Carere DA; VanderWeele T; Moreno TA; Mountain JL; Roberts JS; Kraft P; Green RC;
BMC Med Genomics; 2015 Oct; 8():63. PubMed ID: 26468061
[TBL] [Abstract][Full Text] [Related]
34. An internal performance assessment of CancerGene Connect: an electronic tool to streamline, measure and improve the genetic counseling process.
Pritzlaff M; Yorczyk A; Robinson LS; Pirzadeh-Miller S; Lin T; Euhus D; Ross TS
J Genet Couns; 2014 Dec; 23(6):1034-44. PubMed ID: 24916850
[TBL] [Abstract][Full Text] [Related]
35. Family history and women with ovarian cancer: is it asked and does it matter?: An observational study.
Lanceley A; Eagle Z; Ogden G; Gessler S; Razvi K; Ledermann JA; Side L
Int J Gynecol Cancer; 2012 Feb; 22(2):254-9. PubMed ID: 22274317
[TBL] [Abstract][Full Text] [Related]
36. The clinical impact of family history of cancer in female never-smoker lung adenocarcinoma.
Lee Y; Jeon JH; Goh SH; Roh H; Yun JY; Kwon NJ; Choi JH; Yang HC; Kim MS; Lee JM; Lee GK; Han JY
Lung Cancer; 2019 Oct; 136():15-22. PubMed ID: 31421257
[TBL] [Abstract][Full Text] [Related]
37. Impact of a family history of prostate cancer on clinicopathologic outcomes and survival following radical prostatectomy.
Westerman ME; Gershman B; Karnes RJ; Thompson RH; Rangel L; Boorjian SA
World J Urol; 2016 Aug; 34(8):1115-22. PubMed ID: 26658661
[TBL] [Abstract][Full Text] [Related]
38. The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study.
Collins LC; Baer HJ; Tamimi RM; Connolly JL; Colditz GA; Schnitt SJ
Cancer; 2006 Sep; 107(6):1240-7. PubMed ID: 16902983
[TBL] [Abstract][Full Text] [Related]
39. A positive family history as a risk factor for prostate cancer in a population-based study with organised prostate-specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau).
Randazzo M; Müller A; Carlsson S; Eberli D; Huber A; Grobholz R; Manka L; Mortezavi A; Sulser T; Recker F; Kwiatkowski M
BJU Int; 2016 Apr; 117(4):576-83. PubMed ID: 26332304
[TBL] [Abstract][Full Text] [Related]
40. Estimation of the familial relative risk of cancer by site from a French population based family study on colorectal cancer (CCREF study).
Andrieu N; Launoy G; Guillois R; Ory-Paoletti C; Gignoux M
Gut; 2004 Sep; 53(9):1322-8. PubMed ID: 15306593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
